Private Equity

While private equity activity in healthcare has been high over the last several years, a more recent rise in bankruptcies and defaults points to a possible rough patch for healthcare PE investments. 

Here are what three ASC leaders outlined as pros and cons of private equity in the ASC industry:

On Jan. 8, Gov. Maura Healey signed a bill into law that will increase scrutiny of healthcare transactions, according to a Jan. 10 report from The National Law Review.

Massachusetts Gov. Maura Healey is again eyeing legislation that would increase oversight of private equity activity in healthcare, Mass Live reported Jan. 2. 

While many ASCs remain independent, private equity has become an established force in the industry, with notable movements in 2024.

California and Massachusetts both attempted to pass legislation that would tighten regulations around private equity transactions in healthcare, but it is unlikely that either state will see the proposed bills become law before the end of 2024, Bloomberg reported Dec.…

Here are five recent private equity deals, finalized or rumored, that ASCs are eyeing:

Private equity backed healthcare clinic Forward plans to close its doors just a year after raising $100 million in a Series E funding round, according to a Nov. 13 report from Business Insider.

Private equity activity in healthcare has increased over the last decade, and some states have passed or have pending legislation that could increase scrutiny over private equity deals in healthcare.

Ker Leader Medical, a newly established ASC development company, is committed to preserving the autonomy of physicians and ASC leadership.